Novel bio-inspired lipid nanoparticles for improving the anti-tumoral efficacy of fisetin against breast cancer

被引：16
|
作者：
Talaat, Sara M. [1 ]
Elnaggar, Yosra S. R. [1 ,2 ]
El-Ganainy, Samar O. [3 ]
Gowayed, Mennatallah A. [3 ]
Abdel-Bary, Amany [4 ]
Abdallah, Ossama Y. [1 ]
机构：
[1] Alexandria Univ, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt
[2] Pharos Univ Alexandria, Fac Pharm & Drug Mfg, Head Int Publicat & Nanotechnol Ctr INCC, Dept Pharmaceut, Alexandria, Egypt
[3] Pharos Univ Alexandria, Fac Pharm, Dept Pharmacol & Therapeut, Alexandria, Egypt
[4] Alexandria Univ, Fac Med, Dept Pathol, Alexandria, Egypt
来源：
INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2022年 / 628卷
关键词：
DIETARY FLAVONOID FISETIN; FACTOR-KAPPA-B; APOPTOSIS-INDUCING FACTOR; CELL-CYCLE ARREST; DENSITY-LIPOPROTEIN; TARGETED DELIVERY; IN-VITRO; ORAL BIOAVAILABILITY; ANTICANCER EFFICACY; POLYMERIC MICELLES;
D O I：
10.1016/j.ijpharm.2022.122184
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页数：21
相关论文
共 37 条
  • [31] Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo
    Zheng, Gang
    Zheng, Meizhu
    Yang, Ben
    Fu, Hui
    Li, Yongqing
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 116
  • [32] Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer
    Kang, Sung Wan
    Kang, Ok-Ju
    Lee, Ji-young
    Kim, Hyejeong
    Jung, Hunsoon
    Kim, Hongjoong
    Lee, Shin-Wha
    Kim, Yong Man
    Choi, Eun Kyung
    PLOS ONE, 2024, 19 (02):
  • [33] Evaluation of anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6 and E7 combined with cisplatin in xenograft model of cervical cancer
    Kang, Sung Wan
    Lee, Shin-Wha
    Lee, Ji-Young
    Kang, Ok Ju
    Kim, Hyejeong
    Kim, Yisak
    Kim, Yong-Man
    CANCER RESEARCH, 2023, 83 (07)
  • [34] The Anti-tumoral Effect of β-D-Mannuronic Acid (M2000) as a Novel NSAID on Treg Cells Frequency and MMP-2, MMP-9, CCL22 and TGFβ1 Gene Expression in Pre-surgical Breast Cancer Patients
    Kashefi, Sarvenaz
    Ahmadi, Hamid
    Omranipour, Ramesh
    Mahmoodzadeh, Habibollah
    Jafarnezhad-Ansariha, Fahimeh
    Zavareh, Farzaneh Tofighi
    Mirshafiey, Abbas
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2019, 18 (01) : 80 - 90
  • [35] Efficacy and safety of novel [225Ac]Ac-labeled anti-HER2 antibody drug radioconjugates against HER2 positive breast cancer xenografts
    Ketchemen, J. Pougoue
    Monzar, A.
    Njotu, F. Ngoh
    Babeker, H.
    Tikum, A.
    Nwangele, E.
    Henning, N.
    Hassani, N.
    Doroudi, A.
    Fonge, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S42 - S42
  • [36] Discovery of BCG033, a novel anti-PTK7 x TROP2 bispecific antibody-drug conjugate with promising efficacy against triple-negative breast cancer
    Yao, Sufei
    Shang, Chengzhang
    An, Gao
    Zhang, Ellen
    Lin, Qingcong
    Yang, Yi
    CANCER RESEARCH, 2023, 83 (08)
  • [37] PPAB001, a novel bispecific antibody against CD47 and CD24, enhances anti-PD-L1 efficacy in triple-negative breast cancer via reprogramming tumor-associated macrophages towards M1 phenotype
    Yang, Yun
    Li, Jianqin
    Zhang, Jing
    Wu, He
    Yang, Yan
    Guo, Huaizu
    Zhang, Dapeng
    Ge, Chunpo
    Zhou, Bei
    Ma, Ling
    Dong, Weihua
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 144
1234